Evidence map›Paper›PMID 34115405›Full record

ArticleAndrologia2021

The presence of SARS-CoV-2 virus in semen samples of patients with COVID-19 pneumonia.

Barış Saylam, Mustafa Uguz, Mehmet Yarpuzlu, Ozan Efesoy, Erdem Akbay, Selahittin Çayan

Open access · greenAbstract read
In one paragraph

Article in Andrologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. SARS-CoV-2, fertility and assisted reproduction.Human reproduction update · 2023
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Barış SaylamDepartment of Urology, Mersin City Training and Research Hospital, Mersin, Turkey.ORCID https://orcid.org/0000-0003-3256-8752
Mustafa UguzDepartment of Infectious Diseases, Mersin City Training and Research Hospital, Mersin, Turkey.ORCID https://orcid.org/0000-0002-3428-6137
Mehmet YarpuzluDepartment of Medical Microbiology, Mersin City Training and Research Hospital, Mersin, Turkey.ORCID https://orcid.org/0000-0001-7474-9215
Ozan EfesoyDepartment of Urology, Mersin City Training and Research Hospital, Mersin, Turkey.ORCID https://orcid.org/0000-0002-5650-1686
Erdem AkbayDepartment of Urology, University of Mersin School of Medicine, Mersin, Turkey.ORCID https://orcid.org/0000-0001-7669-414X
Selahittin ÇayanDepartment of Urology, University of Mersin School of Medicine, Mersin, Turkey.ORCID https://orcid.org/0000-0003-4784-2208
Mersin Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 set off a pandemic involving millions of people around the world. The topic of discussion is the possible viral detection in different body fluids than respiratory droplets. Therefore, we evaluated the possible presence of SARS-CoV-2 in semen and urine samples. Thirty patients were included in the study aged 35.67 ± 6.84 years. The day after the pharyngeal and/or nose swab of SARS-CoV-2 was positive, urine and semen samples were taken from patients, and the presence of SARS-CoV-2 was investigated. Laboratory tests and chest CT findings were evaluated simultaneously. SARS-CoV-2 was detected in four (13.3%) patients' semen samples and in seven (23.3%) patients' urine samples. White blood cell (WBC), neutrophil, C-reactive protein (CRP), ferritin, alanine transaminase (ALT), lactate dehydrogenase (LDH) and procalcitonin were significantly higher in patients with SARS-CoV-2 in semen (p < .05), though no statistical difference was found in urine (p > .05). Patients with severe pneumonia findings in Chest CT images are likely to be PCR positive in semen and urine samples (p = .005, p = .001). SARS-CoV-2 was not detected in urine and semen samples of patients after they had recovered (average duration 23 ± 4 days). SARS-CoV-2 can be detected in the urogenıtal fluıds of patients with severe clinical conditions and high viral load.

Indexed as

COVID-19SARS-CoV-2HumansPandemicsRNA, ViralSemenRNA, ViralCOVID-19SARS-CoV-2semenurine

Identifiers

PMID34115405
PMCPMC8420322
OpenAlexW3168131047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.